News

DENVER, Colo. — Research presented today shows that certain lung cancer patients under age 40 are associated with an increased chance for a targeted genomic alteration that may lead to more effective treatments. Dr. Barbara Gitlitz, Associate Professor of Clinical Medicine at the University of Southern California Keck School of Medicine in Los Angeles unveiled the findings at the 16th World Conference on Lung Cancer (WCLC) hosted by the International Association of the Study of Lung Cancer (IASLC).

DENVER, Colo. — The percentage of patients with non-small cell lung cancer (NSCLC) who never smoked is on the rise, according to a report conducted of lung cancer patients in three hospitals in Texas and Tennessee. Dr. Lorraine Pelosof, Assistant Professor, UT Southwestern Medical Center, Dallas, Texas presented the research at the 16th World Conference on Lung Cancer (WCLC) hosted by the International Association of the Study of Lung Cancer (IASLC).

DENVER, Colo. – Lung cancer researchers in Great Britain discovered that the incidence of people who never smoked and were diagnosed with non-small cell lung cancer (NSCLC) increased from 13 percent to 28 percent in a seven-year period. The research was presented today by Dr. Eric Lim, Royal Brompton & Harefield NHS Foundation Trust, London at the 16th World Conference on Lung Cancer (WCLC) hosted by the International Association of the Study of Lung Cancer (IASLC).

DENVER, Colo. – If cancer patients are to receive optimal treatment, clinicians must have an accurate histologic classification of the tumor and know its genetic characteristics, said William D. Travis, M.D., attending thoracic pathologist, Department of Pathology, at Memorial Sloan Kettering Cancer Center in New York City. Dr. Travis made his remarks today at the 16th World Conference on Lung Cancer (WCLC) hosted by the International Association of the Study of Lung Cancer (IASLC).

DENVER, Colo. – The publication of the Eighth Edition of the Tumor, Node and Metastasis (TNM) Classification of Lung Cancer will provide physicians around the world access to new data to more precisely stage and treat cases of lung cancer. That data, collected by the International Association for the Study of Lung Cancer (IASLC) Staging and Prognostic Factors Committee and presented at the 16th World Conference on Lung Cancer (WCLC) in Denver on Tuesday, Sept. 8, 2015 at the Colorado Convention Center, will be published in 2016.

DENVER, Colo. — “Despite tremendous advances in treating lung cancer, there is still no specific, diagnostic approach available to treat women,” said Dr. Silvia Novello, Associate Professor, Department of Oncology, University of Turin-Italy. Dr. Novello made her remarks while opening the press briefing today at the 16th World Conference on Lung Cancer (WCLC) hosted by the International Association of the Study of Lung Cancer (IASLC), which covered many topics including a new edition of the TNM Staging System, the new WHO Classification on Tumors of the Lung and increases in the number of lung cancer in patients who never smoked.

Pages